Clinical outcomes of HIV-1 infected patients switched from complex multi-tablet regimens to tenofovir alafenamide based single-tablet regimens plus a boosted protease inhibitor in a real-world setting

BACKGROUND: Multi-tablet regimens (MTRs) are associated with increased adverse events and non-adherence. Single tablet regimens (STRs) plus boosted protease inhibitors (PIs) are a simplification option for MTR-treated patients; however, data is needed to validate this therapeutic strategy. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Rolle, Charlotte-Paige, Nguyen, Vu, Hinestrosa, Federico, DeJesus, Edwin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7670251/
https://www.ncbi.nlm.nih.gov/pubmed/33329900
http://dx.doi.org/10.1016/j.jve.2020.100021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7670251/
https://www.ncbi.nlm.nih.gov/pubmed/33329900
http://dx.doi.org/10.1016/j.jve.2020.100021

Ejemplares similares